Complete Filing Data
Q32 Bio Inc. reported Stockholders Equity of $42.01 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Q32 Bio Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $29.8M | -$47.7M | -$53.7M | -$5.0M | -$95.8M | -$128.7M | -$103.9M | -$55.6M | -$30.0M |
| Revenue * | $53.7M | $0.00 | $1.2M | $3.2M | $34.0M | $2.7M | $1.7M | $5.3M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $0.00 | -$397.0K | -$7.0K | -$183.0K | $260.0K | -$4.0K | -$73.0K |
| Operating Income Loss | $16.9M | -$66.1M | -$48.3M | -$133.3M | -$95.9M | -$130.3M | -$109.9M | -$59.9M | -$29.7M |
| Research And Development Expense | $19.2M | $48.1M | $31.7M | $98.4M | $93.1M | $100.4M | $89.4M | $47.9M | $21.4M |
| Other Nonoperating Income Expense | $1.2M | $4.1M | $1.0M | $134.5M | $185.0K | $1.6M | $6.0M | $4.3M | -$334.0K |
| Operating Expenses | $36.8M | $66.1M | $41.6M | $136.5M | $129.9M | $133.0M | $111.6M | $65.2M | $29.7M |
| General And Administrative Expense | $17.7M | $18.0M | $9.9M | $38.1M | $36.8M | $32.6M | $22.2M | $17.3M | $8.3M |
| Comprehensive Income Net Of Tax | $29.8M | -$47.7M | -$53.7M | -$5.4M | -$95.8M | -$128.9M | -$103.7M | -$55.6M | -$30.1M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | -$397.0K | -$7.0K | -$183.0K | $260.0K | -$4.0K | -$73.0K |
| Income Tax Expense Benefit | $0.00 | $21.0K | $318.0K | $715.0K | $0.00 | ||||
| Investment Income Nonoperating | $5.6M | $3.2M | $185.0K | $1.6M | $6.0M | $4.3M | $542.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$87.1M | $1.2M | -$95.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.4M | -$9.5M | -$11.0M | -$17.6M | -$17.0M | $1.0M | -$14.0M | -$5.8M | -$6.8M | -$33.7M | -$29.1M | $92.1M | -$30.6M | -$30.5M | -$1.1M | -$28.2M | -$35.3M | -$35.3M | -$29.6M | -$26.3M | -$23.9M | -$14.1M | -$12.4M | -$10.2M | -$6.5M | -$6.0M | -$5.6M |
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $354.0K | $802.0K | $802.0K | $802.0K | $802.0K | $1.7M | $2.2M | $29.3M | $567.0K | $567.0K | $588.0K | $441.0K | $392.0K | $270.0K | $1.6M | $1.4M | $1.1M | ||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $4.0K | -$5.0K | $0.00 | $0.00 | $0.00 | -$416.0K | -$41.0K | $7.0K | -$7.0K | $25.0K | -$23.0K | -$11.0K | $30.0K | -$202.0K | $68.0K | $180.0K | $83.0K | $28.0K | $38.0K | -$13.0K | |||
| Operating Income Loss | -$7.6M | -$9.2M | -$12.2M | -$18.8M | -$17.9M | -$14.8M | -$7.8M | -$7.3M | -$7.4M | -$32.9M | -$28.3M | -$37.6M | -$30.7M | -$30.6M | -$1.1M | -$28.3M | -$35.7M | -$36.5M | -$31.3M | -$28.0M | -$25.1M | -$15.6M | -$13.4M | -$10.7M | -$6.7M | -$6.0M | -$4.7M |
| Research And Development Expense | $3.6M | $5.2M | $7.1M | $14.3M | $13.4M | $9.8M | $7.5M | $8.0M | $7.9M | $25.9M | $21.1M | $24.3M | $24.0M | $23.7M | $21.8M | $20.4M | $27.5M | $29.3M | $25.7M | $22.8M | $20.5M | $13.4M | $10.3M | $8.0M | $4.9M | $4.1M | $2.8M |
| Other Nonoperating Income Expense | $188.0K | -$318.0K | $1.2M | $1.2M | $2.4M | $158.0K | $84.0K | $165.0K | $578.0K | $1.3M | $474.0K | $131.3M | $53.0K | $52.0K | $38.0K | $41.0K | $357.0K | $1.2M | $1.7M | $1.7M | $1.3M | $1.5M | $996.0K | $479.0K | $137.2K | $35.8K | -$863.3K |
| Operating Expenses | $7.6M | $9.2M | $12.2M | $18.8M | $17.9M | $14.8M | $9.7M | $10.5M | $10.3M | $33.7M | $29.1M | $38.4M | $32.3M | $32.7M | $30.4M | $28.8M | $36.3M | $37.1M | $31.7M | $28.4M | $25.4M | $17.2M | $14.8M | $11.8M | $6.7M | $6.0M | $4.7M |
| General And Administrative Expense | $4.0M | $4.0M | $5.1M | $4.5M | $4.5M | $5.0M | $2.2M | $2.5M | $2.4M | $7.8M | $8.0M | $14.1M | $8.4M | $9.0M | $8.7M | $8.4M | $8.8M | $7.8M | $6.0M | $5.5M | $4.9M | $3.8M | $4.5M | $3.8M | $1.7M | $2.0M | $1.9M |
| Comprehensive Income Net Of Tax | -$7.4M | -$9.5M | -$11.0M | -$17.6M | -$17.0M | $1.0M | -$14.0M | -$5.8M | -$6.8M | -$34.1M | -$29.1M | $92.1M | -$30.6M | -$30.5M | -$1.1M | -$28.2M | -$35.3M | -$35.5M | -$29.6M | -$26.1M | -$23.8M | -$14.1M | -$12.4M | -$10.2M | -$6.5M | -$6.0M | -$5.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $4.0K | -$5.0K | $0.00 | $0.00 | $0.00 | -$416.0K | -$41.0K | $7.0K | -$7.0K | $25.0K | -$23.0K | -$11.0K | $30.0K | -$202.0K | $68.0K | $180.0K | $83.0K | $28.0K | $38.0K | -$13.0K | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$65.0K | $0.00 | $0.00 | $46.0K | $105.0K | $967.0K | $0.00 | $0.00 | $0.00 | |||||||||||||
| Investment Income Nonoperating | $53.0K | $52.0K | $38.0K | $41.0K | $357.0K | $1.2M | $1.7M | $1.7M | $1.3M | $1.5M | $996.0K | $479.0K | $137.2K | $35.8K | $12.7K | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$29.6M | -$29.3M | -$26.0M | -$31.6M | -$27.8M | $93.7M | -$30.6M | -$30.5M | -$1.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $42.0M | $5.7M | -$182.9M | -$130.7M | $169.7M | $196.0M | $258.5M | $196.4M | -$39.5M | -$9.9M |
| Cash And Cash Equivalents At Carrying Value | $48.3M | $78.0M | $25.6M | $34.0M | $108.4M | $217.4M | $53.8M | $38.2M | $51.6M | $11.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $39.3M | $34.0M | $110.3M | $218.7M | $55.0M | $40.0M | $53.3M | |||
| Retained Earnings Accumulated Deficit | -$205.0M | -$234.8M | -$187.1M | -$429.1M | -$424.1M | -$328.4M | -$199.7M | -$95.8M | -$40.2M | |
| Property Plant And Equipment Net | $979.0K | $1.4M | $1.8M | $1.1M | $2.3M | $37.0M | $42.7M | $35.6M | $3.2M | |
| Prepaid Expense And Other Assets Current | $6.8M | $3.9M | $3.1M | $6.0M | $7.1M | $2.1M | $4.2M | $6.9M | $1.9M | |
| Liabilities Current | $11.3M | $16.5M | $14.1M | $22.6M | $17.2M | $22.7M | $12.4M | $22.5M | $8.9M | |
| Liabilities And Stockholders Equity | $61.8M | $92.3M | $47.1M | $228.5M | $211.7M | $263.7M | $310.6M | $259.1M | $137.5M | |
| Liabilities | $19.8M | $86.7M | $118.5M | $50.5M | $42.1M | $67.7M | $52.1M | $62.7M | $39.2M | |
| Assets Current | $55.1M | $81.9M | $28.7M | $181.0M | $191.9M | $219.6M | $266.6M | $221.7M | $131.6M | |
| Assets | $61.8M | $92.3M | $47.1M | $228.5M | $211.7M | $263.7M | $310.6M | $259.1M | $137.5M | |
| Accounts Payable Current | $879.0K | $3.0M | $3.5M | $1.1M | $2.4M | $4.7M | $2.6M | $15.7M | $2.5M | |
| Common Stock Value | $2.0K | $2.0K | $1.0K | $6.0K | $6.0K | $5.0K | $4.0K | $3.0K | ||
| Accrued Expenses And Other Liabilities Current | $4.2M | $7.5M | $9.8M | $18.7M | $11.4M | $9.8M | $7.6M | $5.0M | $2.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $221.0K | $0.00 | $1.9M | $894.0K | $198.0K | $1.9M | $1.6M | $85.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$404.0K | -$7.0K | $0.00 | $183.0K | -$77.0K | -$73.0K | |||
| Restricted Cash | $0.00 | $2.0M | $1.3M | $1.3M | $1.8M | $1.8M | ||||
| Operating Lease Right Of Use Asset | $5.1M | $5.7M | $6.3M | $20.6M | $15.6M | $5.9M | $6.8M | |||
| Operating Lease Liability Noncurrent | $4.9M | $5.6M | $6.2M | $27.9M | $23.7M | $12.9M | ||||
| Stock Issued During Period Value Vesting Of Common Stock From Option Exercise | $13.0K | $24.0K | $60.0K | $75.0K | $225.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.3M | -$76.3M | -$108.4M | $163.7M | $15.1M | -$13.4M | ||||
| Contract With Customer Liability Current | $0.00 | $1.2M | $3.2M | $5.6M | $809.0K | $770.0K | ||||
| Available For Sale Securities Debt Securities Current | $141.0M | $47.5M | $0.00 | $208.6M | $176.5M | $78.1M | ||||
| Reclassification Of Liability For Common Stock Vested In Noncash Transactions | $0.00 | $13.0K | $24.0K | $60.0K | $75.0K | $225.0K | ||||
| Operating Lease Liability Current | $1.3M | $1.6M | $246.0K | $2.5M | $15.4M | |||||
| Additional Paid In Capital Common Stock | $615.1M | $607.5M | $593.8M | $524.4M | $458.0M | $292.2M | $800.0K | |||
| Property And Equipment Additions Included In Accrued Expenses And Other Liabilities | $0.00 | $8.0K | $116.0K | $249.0K | ||||||
| Non Cash Lease Expense | $2.1M | $1.3M | $1.2M | $939.0K | ||||||
| Gain Loss On Sale Of Property Plant Equipment | $94.0K | -$49.0K | -$133.0K | -$888.0K | -$13.0K | -$127.0K | ||||
| Contract With Customer Liability Noncurrent | $0.00 | $1.2M | $32.1M | $30.1M | $30.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$18.4M | -$12.2M | -$4.0M | $18.3M | $33.5M | $48.8M | -$156.5M | -$142.7M | -$137.2M | $209.1M | $240.3M | $266.3M | $198.6M | $224.6M | $200.8M | $170.2M | $194.7M | $226.5M | $257.8M | $284.7M | $174.3M | $214.2M | $227.6M | -$49.2M | ||||||
| Cash And Cash Equivalents At Carrying Value | $49.0M | $54.8M | $65.5M | $89.1M | $97.7M | $115.5M | $36.3M | $20.1M | $31.4M | $43.2M | $176.2M | $248.1M | $95.8M | $116.3M | $104.4M | $178.0M | $167.6M | $143.4M | $77.6M | $115.6M | $40.8M | $36.0M | $95.0M | $46.2M | $97.8M | $20.4M | $26.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $29.1M | $76.8M | $39.5M | $43.2M | $176.2M | $248.4M | $97.1M | $117.6M | $105.7M | $179.3M | $168.9M | $144.6M | $78.8M | $116.8M | $42.1M | $37.8M | $96.8M | $48.0M | ||||||||||||
| Retained Earnings Accumulated Deficit | -$262.7M | -$255.3M | -$245.8M | -$220.6M | -$203.0M | -$186.1M | -$526.0M | -$493.0M | -$458.0M | -$394.8M | -$361.1M | -$332.0M | -$390.5M | -$359.9M | -$329.4M | -$298.6M | -$270.3M | -$235.0M | -$175.5M | -$145.9M | -$119.6M | -$78.4M | -$63.6M | -$50.7M | ||||||
| Property Plant And Equipment Net | $1.1M | $1.2M | $1.3M | $1.5M | $1.6M | $1.7M | $0.00 | $845.0K | $1.1M | $1.4M | $1.7M | $2.0M | $32.7M | $34.4M | $36.2M | $39.7M | $40.8M | $42.6M | $41.4M | $41.1M | $41.0M | $20.7M | $6.9M | $3.8M | ||||||
| Prepaid Expense And Other Assets Current | $1.8M | $3.5M | $3.1M | $4.8M | $4.0M | $2.7M | $3.0M | $4.3M | $3.6M | $12.1M | $12.9M | $6.3M | $4.3M | $4.6M | $3.0M | $3.3M | $3.2M | $3.4M | $4.4M | $3.0M | $2.5M | $8.3M | $6.1M | $3.7M | ||||||
| Liabilities Current | $11.1M | $11.5M | $14.6M | $14.4M | $17.2M | $33.0M | $25.3M | $22.9M | $18.5M | $25.3M | $20.7M | $20.8M | $18.7M | $19.5M | $17.8M | $17.2M | $19.6M | $17.5M | $18.7M | $15.5M | $17.6M | $18.6M | $10.9M | $9.4M | ||||||
| Liabilities And Stockholders Equity | $57.8M | $66.1M | $79.1M | $104.5M | $124.2M | $152.3M | $140.1M | $169.3M | $197.9M | $262.7M | $284.6M | $311.0M | $230.8M | $258.9M | $234.7M | $228.4M | $258.2M | $288.8M | $316.8M | $341.2M | $233.0M | $268.4M | $270.3M | $129.1M | ||||||
| Liabilities | $76.2M | $78.4M | $83.1M | $86.2M | $90.7M | $103.6M | $51.9M | $50.0M | $46.0M | $53.6M | $44.3M | $44.7M | $32.2M | $34.3M | $33.9M | $58.1M | $63.5M | $62.2M | $58.9M | $56.4M | $58.8M | $55.6M | $43.5M | $40.8M | ||||||
| Assets Current | $50.8M | $58.3M | $68.6M | $93.9M | $111.6M | $138.0M | $106.6M | $131.3M | $153.6M | $213.2M | $238.4M | $262.4M | $191.8M | $217.9M | $191.7M | $181.3M | $209.8M | $238.3M | $274.1M | $298.8M | $190.5M | $245.9M | $261.6M | $120.4M | ||||||
| Assets | $57.8M | $66.1M | $79.1M | $104.5M | $124.2M | $152.3M | $140.1M | $169.3M | $197.9M | $262.7M | $284.6M | $311.0M | $230.8M | $258.9M | $234.7M | $228.4M | $258.2M | $288.8M | $316.8M | $341.2M | $233.0M | $268.4M | $270.3M | $129.1M | ||||||
| Accounts Payable Current | $973.0K | $910.0K | $2.7M | $1.3M | $2.5M | $5.0M | $7.8M | $3.4M | $3.6M | $4.8M | $3.8M | $9.9M | $3.5M | $5.7M | $4.9M | $3.3M | $7.1M | $7.4M | $8.8M | $8.3M | $11.8M | $11.1M | $5.0M | $3.8M | ||||||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.7K | $3.7K | $270.00 | $264.00 | |||||
| Accrued Expenses And Other Liabilities Current | $3.9M | $4.4M | $5.3M | $8.9M | $11.0M | $19.8M | $15.7M | $17.8M | $12.9M | $17.0M | $12.9M | $6.3M | $10.0M | $7.7M | $5.4M | $8.4M | $9.3M | $6.9M | $7.8M | $5.3M | $3.8M | $3.8M | $2.4M | $2.3M | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $909.0K | -$38.0K | -$162.0K | $175.0K | $661.0K | $123.0K | ||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | -$1.0K | -$1.0K | -$5.0K | -$36.0K | -$88.0K | -$182.0K | -$457.0K | -$41.0K | -$5.0K | $2.0K | -$23.0K | $11.0K | -$19.0K | $254.0K | $186.0K | $6.0K | -$20.9K | -$48.6K | -$86.2K | |||||||
| Restricted Cash | $0.00 | $0.00 | $276.0K | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.8M | $1.8M | $1.8M | |||||||||||||||
| Operating Lease Right Of Use Asset | $5.3M | $5.4M | $5.6M | $5.9M | $6.0M | $6.2M | $19.5M | $19.8M | $20.2M | $20.9M | $15.2M | $15.6M | $5.0M | $5.3M | $5.6M | $6.1M | $6.4M | $6.6M | ||||||||||||
| Operating Lease Liability Noncurrent | $5.1M | $5.3M | $5.5M | $5.8M | $5.9M | $6.1M | $26.6M | $27.0M | $27.5M | $28.3M | $23.6M | $23.5M | $11.6M | $12.0M | $12.5M | $13.5M | $14.2M | $14.8M | ||||||||||||
| Stock Issued During Period Value Vesting Of Common Stock From Option Exercise | $3.0K | $4.0K | $4.0K | $5.0K | $4.0K | $12.0K | $11.0K | $18.0K | $18.0K | $51.0K | -$10.0K | $16.0K | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.5M | $138.1M | -$113.0M | $89.6M | $2.1M | -$5.4M | ||||||||||||||||||||||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $354.0K | $2.0M | $2.8M | $3.2M | $3.2M | $4.0M | $5.2M | $2.9M | $774.0K | $774.0K | $774.0K | $690.0K | $905.0K | |||||||||||||||
| Available For Sale Securities Debt Securities Current | $10.0M | $19.8M | $0.00 | $157.9M | $49.3M | $8.0M | $91.7M | $97.0M | $84.2M | $39.0M | $91.6M | $192.1M | $180.2M | $147.1M | $201.5M | $160.5M | $70.5M | |||||||||||||
| Reclassification Of Liability For Common Stock Vested In Noncash Transactions | $4.0K | $12.0K | $18.0K | $16.0K | $20.6K | |||||||||||||||||||||||||
| Operating Lease Liability Current | $1.8M | $1.7M | $1.6M | $1.5M | $410.0K | $435.0K | $2.0M | $2.1M | $2.3M | $2.5M | $2.4M | $2.3M | ||||||||||||||||||
| Additional Paid In Capital Common Stock | $604.4M | $601.4M | $598.3M | $589.1M | $584.5M | $530.3M | $468.8M | $465.0M | $461.6M | $433.1M | $430.4M | $293.9M | $291.2M | $290.4M | $1.3M | |||||||||||||||
| Property And Equipment Additions Included In Accrued Expenses And Other Liabilities | $0.00 | $5.0K | $164.0K | $23.0K | ||||||||||||||||||||||||||
| Non Cash Lease Expense | $362.0K | $197.0K | $279.0K | $221.0K | ||||||||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$11.0K | $0.00 | -$6.0K | |||||||||||||||||||||||||||
| Contract With Customer Liability Noncurrent | $354.0K | $2.0M | $2.8M | $3.6M | $27.4M | $29.8M | $30.0M | $30.4M | $30.6M | $30.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$3.1M | $95.1M | $406.0K | $596.0K | $52.2M | $53.1M | $158.2M | $151.0M | $115.2M |
| Investing Cash Flow * | $7.0M | $19.9M | -$5.0K | $36.7M | -$50.8M | $204.9M | -$51.8M | -$121.8M | -$81.5M |
| Operating Cash Flow * | -$33.5M | -$67.7M | -$18.7M | -$113.7M | -$109.8M | -$94.3M | -$91.4M | -$42.6M | $6.5M |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $5.3M | $4.4M | $1.4M | $13.1M | $17.2M | $13.2M | $7.6M | $2.6M | $256.0K |
| Share Based Compensation | $5.3M | $4.4M | $1.4M | $13.1M | $17.2M | $13.2M | $7.6M | $2.6M | $277.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.9M | -$276.0K | $94.0K | -$840.0K | $5.0M | -$2.1M | -$2.8M | $5.0M | $1.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.3M | -$7.7M | $199.0K | $7.4M | $1.5M | $2.4M | $2.3M | $3.0M | $864.0K |
| Increase Decrease In Accounts Payable | -$2.1M | -$1.0M | $2.0M | -$981.0K | -$2.5M | $2.5M | -$4.5M | $4.4M | $1.7M |
| Payments To Acquire Property Plant And Equipment | $0.00 | $75.0K | $5.0K | $1.3M | $2.4M | $3.7M | $21.8M | $24.9M | $2.0M |
| Proceeds From Stock Options Exercised | $0.00 | $1.7M | $106.0K | $1.0K | $145.0K | $176.0K | $351.0K | $87.0K | |
| Increase Decrease In Contract With Customer Liability | -$1.2M | -$3.2M | -$33.4M | $6.8M | -$569.0K | -$1.9M | |||
| Payments To Acquire Available For Sale Securities Debt | $73.2M | $157.5M | $97.4M | $20.0M | $286.4M | $245.3M | $78.1M | ||
| Proceeds From Sale Of Available For Sale Securities Debt | $174.2M | $65.5M | $49.0M | $228.6M | $256.4M | $148.5M | |||
| Proceeds From Stock Plans | $168.0K | $595.0K | $826.0K | $938.0K | $829.0K | ||||
| Increase Decrease In Operating Lease Liabilities | -$1.4M | -$719.0K | -$2.4M | -$2.3M | |||||
| Proceeds From Issuance Of Common Stock | $0.00 | $42.0M | $0.00 | $0.00 | $49.7M | $134.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $99.3M | $15.0K | $440.0K | $2.0M | $447.0K | $325.0K | -$958.0K | $20.5M | |||||||||||||||||
| Investing Cash Flow * | $0.00 | $97.0K | -$5.0K | $168.3M | -$85.2M | $115.0M | $19.7M | $6.6M | -$848.4K | ||||||||||||||||
| Operating Cash Flow * | -$12.5M | -$14.6M | -$12.5M | -$30.7M | -$29.8M | -$25.8M | -$17.9M | -$11.0M | -$4.5M | ||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.2M | $1.3M | $1.3M | $1.4M | $1.3M | $417.0K | $301.0K | $310.0K | $296.0K | $2.8M | $3.1M | $4.1M | $4.2M | $4.5M | $3.9M | $3.3M | $3.5M | $2.9M | $2.0M | $2.0M | $1.2M | $719.0K | $569.0K | $380.0K | |
| Share Based Compensation | $1.3M | $417.0K | $296.0K | $4.1M | $3.9M | $2.9M | $1.2M | $380.0K | $27.7K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$763.0K | -$1.3M | -$426.0K | -$507.0K | $870.0K | -$1.1M | -$4.4M | $1.7M | $390.9K | ||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.2M | -$2.2M | -$2.8M | -$5.0M | -$4.5M | -$535.0K | -$1.4M | -$764.0K | -$69.1K | ||||||||||||||||
| Increase Decrease In Accounts Payable | -$277.0K | $928.0K | -$823.0K | $7.7M | -$100.0K | $4.8M | -$85.0K | $511.0K | $350.4K | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $5.0K | $1.1M | $817.0K | $2.0M | $10.5M | $1.0M | $848.4K | |||||||||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $15.0K | $1.0K | $143.0K | $135.0K | $21.0K | $69.0K | ||||||||||||||||||
| Increase Decrease In Contract With Customer Liability | -$802.0K | -$802.0K | -$29.0M | -$203.0K | -$92.0K | -$463.0K | |||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $25.3M | $0.00 | $84.4M | $84.5M | $18.6M | ||||||||||||||||||||
| Proceeds From Sale Of Available For Sale Securities Debt | $0.00 | $39.5M | $117.0M | $114.6M | $26.3M | ||||||||||||||||||||
| Proceeds From Stock Plans | $150.0K | $439.0K | $446.0K | $537.0K | $396.0K | ||||||||||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$375.0K | -$150.0K | -$621.0K | -$541.0K | |||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $42.0M | $0.00 | $1.5M | $69.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.42 | -$6.58 | -$153.96 | -$0.09 | -$1.73 | -$2.80 | -$2.47 | -$1.95 | -$12.10 |
| Common Stock Shares Outstanding | 12.9M | 12.2M | 359.6K | 57.5M | 57.2M | 50.3M | 45.1M | 37.4M | 2.6M |
| Common Stock Shares Issued | 12.9M | 12.2M | 359.6K | 57.5M | 57.2M | 50.3M | 45.1M | 37.5M | 2.9M |
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 170.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 12.3M | 9.3M | 349.1K | 57.4M | 55.3M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 12.3M | 9.7M | 349.1K | 57.4M | 55.3M | ||||
| Earnings Per Share Basic | $2.42 | $-5.12 | $-153.96 | $-0.09 | $-1.73 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 55.3M | 45.9M | 42.1M | 28.6M | 2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.60 | -$0.78 | -$0.90 | -$1.46 | -$1.42 | -$6.33 | -$40.52 | -$16.69 | -$19.84 | -$0.59 | -$0.51 | $1.59 | -$0.54 | -$0.54 | -$0.02 | -$0.62 | -$0.78 | -$0.78 | -$0.67 | -$0.61 | -$0.64 | -$0.38 | -$0.34 | -$4.09 | -$2.78 | -$2.61 | -$2.79 |
| Common Stock Shares Outstanding | 12.3M | 12.2M | 12.2M | 12.1M | 12.0M | 11.9M | 57.9M | 57.8M | 57.8M | 57.5M | 57.4M | 57.4M | 57.1M | 57.1M | 50.5M | 45.3M | 45.2M | 45.2M | 44.0M | 43.9M | 37.4M | 37.3M | 37.3M | 2.7M | |||
| Common Stock Shares Issued | 12.3M | 12.2M | 12.2M | 12.1M | 12.0M | 11.9M | 57.9M | 57.8M | 57.8M | 57.5M | 57.4M | 57.4M | 57.2M | 57.1M | 50.5M | 45.3M | 45.2M | 45.2M | 44.0M | 44.0M | 37.6M | 37.5M | 37.5M | 2.9M | |||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 170.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 12.2M | 12.2M | 12.2M | 12.1M | 12.0M | 995.3K | 346.3K | 347.9K | 344.6K | 57.4M | 57.4M | 57.3M | 57.1M | 56.5M | 50.4M | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 12.2M | 12.2M | 12.2M | 12.1M | 12.0M | 2.3M | 346.3K | 347.9K | 344.6K | 57.4M | 57.4M | 57.9M | 57.1M | 56.5M | 50.4M | ||||||||||||
| Earnings Per Share Basic | $-0.60 | $-0.78 | $-0.90 | $-1.46 | $-1.42 | $1.03 | $-40.52 | $-16.69 | $-19.84 | $-0.59 | $-0.51 | $1.61 | $-0.54 | $-0.54 | $-0.02 | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 57.1M | 56.5M | 50.4M | 45.2M | 45.2M | 45.2M | 43.9M | 43.1M | 37.4M | 37.3M | 36.9M | 2.5M | 2.4M | 2.3M | 2.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $391.0K | $487.0K | $499.0K | $1.3M | $8.4M | $8.0M | $6.3M | $1.3M | $684.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.7M | $106.0K | $1.0K | $145.0K | $176.0K | $351.0K | $87.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $961.0K | $856.0K | $422.0K | $0.00 | $241.0K | $110.0K | $455.0K | $9.1M | $167.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $168.0K | $595.0K | $826.0K | $938.0K | $829.0K | ||||
| Gain Loss On Sale Of Business | $0.00 | $131.2M | $0.00 | ||||||
| Interest Income |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $100.0K | $100.0K | $119.0K | $100.0K | $100.0K | $123.0K | $100.0K | $200.0K | $127.0K | $300.0K | $300.0K | $348.0K | $2.1M | $2.1M | $2.1M | $2.0M | $2.0M | $1.9M | $1.7M | $1.6M | $1.3M | $300.0K | $200.0K | $221.0K | $200.0K | $130.2K |
| Stock Issued During Period Value Stock Options Exercised | $997.0K | $380.0K | $15.0K | $15.0K | $1.0K | $2.0K | $143.0K | $9.0K | $16.0K | $135.0K | $209.0K | $55.0K | $21.0K | -$40.0K | $16.0K | $69.0K | ||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $247.0K | $115.0K | $119.0K | $59.0K | $367.0K | $405.0K | $5.3M | $27.0K | $214.7K | |||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $18.0K | $150.0K | $124.0K | $439.0K | $380.0K | $446.0K | $401.0K | $537.0K | $433.0K | $396.0K | ||||||||||||||||
| Gain Loss On Sale Of Business | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $131.2M | $0.00 | |||||||||||||||||||
| Interest Income | $1.4M | $1.5M | $1.5M | $1.3M | $474.0K | $32.0K | $53.0K | $52.0K | $38.0K |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.